Inspire Medical Systems develops and markets medical devices for treating obstructive sleep apnea, primarily through its neurostimulation technology that stimulates the hypoglossal nerve to keep airways open during sleep. The company's primary offering uses a closed-loop system that detects breathing patterns and delivers targeted stimulation to maintain airway patency in patients with moderate to severe sleep apnea. Based in Minnesota, the firm operates across the United States and international markets.

entry readiness 15 · NOT READY · exit proximity 0

Value area 38.91–66.04 · 26% of 120d volume overhead · moderate overhead